PLAY PODCASTS
Novartis posts Q3 income beat, reaffirms FY2025 guidance

Novartis posts Q3 income beat, reaffirms FY2025 guidance

Squawk Box Europe Express · CNBC International

October 28, 202525m 6s

Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Swiss pharma giant Novartis sees Q3 income up by a quarter, allowing it to achieve its FY guidance and countering the fall in generic drug sales Stateside. BNP maintains its forecasts despite Q3 net income and revenue missing expectations. The French bank says it is determined to appeal a U.S. jury’s verdict that ruled it breached sanctions on Sudan during the reign of President Omar al-Bashir. UK lender HSBC sees Q3 profits fall by 14 per cent on the back of legal provisions on a Bernie Madoff-related lawsuit. However, the bank still beat forecasts and hiked its net income guidance for the year.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Topics

stock market newsmarket newsKaren TsoEurope business newssquawk box podcastArabile Gumedeeurope cnbcCNBC LondonEuropean business newseurope squawk boxGeoff CutmoreCNBC podcastCNBC EuropeSteve SedgwickCNBC podcastsSquawk Box EuropeCNBC InternationalEurope newsstocksCNBCinvestingmarketsPOLITICSEconomicsmoneyFinancial MarketsSquawk BoxBusiness NewsNOVARTISHSBCBernie MadoffBNP PARIBAS